| Literature DB >> 35621977 |
Muneera S M Al-Saleem1, Wafaa H B Hassan2, Zeinab I El Sayed2, Mahmoud M Abdel-Aal2, Wael M Abdel-Mageed3,4, Eman Abdelsalam2, Sahar Abdelaziz2.
Abstract
Marine sponge-derived endozoic fungi have been gaining increasing importance as promising sources of numerous and unique bioactive compounds. This study investigates the phytochemical profile and biological activities of the ethyl acetate extract of Penicillium chrysogenum derived from Cliona sp. sponge. Thirty-six compounds were tentatively identified from P. chrysogenum ethyl acetate extract along with the kojic acid (KA) isolation. The UPLC-ESI-MS/MS positive ionization mode was used to analyze and identify the extract constituents while 1D and 2D NMR spectroscopy were used for kojic acid (KA) structure confirmation. The antimicrobial, antioxidant, and cytotoxic activities were assessed in vitro. Both the extract and kojic acid showed potent antibacterial activity against Staphylococcus aureus and Pseudomonas aeruginosa with MIC 250 ± 0.82 µg/mL. Interestingly, the extract showed strong antifungal activity against Candida albicans and Cryptococcus neoformans with MIC 93.75 ± 0.55 and 19.53 ± 0.48 µg/mL, respectively. Furthermore, KA showed the same potency against Fusarium oxysporum and Cryptococcus neoformans with MIC 39.06 ± 0.85 and 39.06 ± 0.98 µg/mL, respectively. Ultimately, KA showed strong antioxidant activity with IC50 33.7 ± 0.8 µg/mL. Moreover, the extract and KA showed strong cytotoxic activity against colon carcinoma (with IC50 22.6 ± 0.8 and 23.4 ± 1.4 µg/mL, respectively) and human larynx carcinoma (with equal IC50 30.8 ± 1.3 and ± 2.1 µg/mL, respectively), respectively. The current study represents the first insights into the phytochemical profile and biological properties of P. chrysoenum ethyl acetate extract, which could be a promising source of valuable secondary metabolites with potent biological potentials.Entities:
Keywords: Cliona sp.; Penicillium chrysogenum; UPLC-ESI-MS/MS; antimicrobial; antioxidant; cytotoxicity; marine sponge-derived fungi
Mesh:
Substances:
Year: 2022 PMID: 35621977 PMCID: PMC9143181 DOI: 10.3390/md20050326
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 6.085
Screening for antimicrobial activity of endophytic fungi inhabiting the tested medicinal sponge.
| Fungal Isolates | Gram Positive Bacteria | Gram Negative Bacteria | Fungi | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| IZ | MIC | IZ | MIC | IZ | MIC | IZ | MIC | |||
| 1 | 28 | 2000 | - | - | - | - | 14 | >3000 | ||
| 2 | 14 | 1000 | - | - | - | - | - | - | ||
| 3 | - | - | - | - | - | - | 14 | >3000 | ||
| 4 | 23 | 250 | - | - | - | - | 40 | 93.75 | ||
| 1 | 19 | 250 | - | - | - | 20 | 187.5 | |||
| 2 | - | - | - | - | - | - | - | - | ||
| 3 | - | - | - | - | - | - | - | - | ||
| 4 | 14 | >2000 | 14 | >2000 | 25 | 250 | 25 | 750 | ||
| 5 | 20 | >2000 | 15 | >2000 | 23 | >2000 | 25 | >3000 | ||
| 9 | 21 | >2000 | 14 | >2000 | - | - | 18 | >1500 | ||
| 7 | - | - | - | - | - | - | 14 | >3000 | ||
| 8 | - | - | - | - | - | - | - | - | ||
| Ciprofloxacin | - | 1.56 ± 1.2 | - | 3.125 ± 0.89 | - | 3.125 ± 0.24 | - | - | ||
| Fluconazole | - | - | - | - | - | - | 42 ± 0.58 | 50 ± 0.24 | ||
| DMSO (Negative control) | 10 | - | 10 | - | 19 | - | 12 | - | ||
IZ: Inhibition zone (mm) diameter; MIC: Minimum Inhibitory Concentration (μg/mL). MIC: 50–500 μg/mL (strong activity), 600–1500 μg/mL (moderate activity), >1500 μg/mL (weak activity) [18,19].
Phytochemicals tentatively identified in Penicillium chrysogenum ethyl acetate extract using UPLC-ESI-MS/MS analysis in positive ionization mode.
| No. | Compound Name | Rt (min.) | Parent ion | MS2 Fragments | Area% Total | Reference |
|---|---|---|---|---|---|---|
| 1 | Amphetamine * | 0.79 | 136.0710 [M + H]+ | 119, 92, 54 | 1.51 | [ |
| 2 | Pyrroline carboxylic acid | 0.88 | 115.0515 [M + 2H]+ | 96, 69, 41 | 0.50 | [ |
| 3 | 3-hydroxy kojic acid * | 1.03 | 159.1239 [M + H]+ | 143, 125, 113, 96, 69 | 0.18 | [ |
| 4 | Kojic acid | 1.13 | 143.0706 [M + H]+ | 126, 113, 97, 69 | 2.87 | [ |
| 5 | Aspyrone * | 1.20 | 185.1388 [M + H]+ | 167, 139, 125 | 0.50 | [ |
| 6 | Flufuran * | 1.35 | 143.0601 [M + H]+ | 125, 113, 96, 69 | 0.59 | [ |
| 7 | Pyrroline carboxylic acid isomer | 1.84 | 115.0537 [M + 2H]+ | 96, 69, 41 | 0.50 | [ |
| 8 | N-methyl-benzodioxazoylbutanamine (MBDB) | 2.15 | 208.0558 [M + H]+ | 177, 136, 85 | 0.59 | [ |
| 9 | Asperlactone * | 3.35 | 185.1051 [M + H]+ | 158, 141, 128, 113, 98 | 0.77 | [ |
| 10 | Acetyl Kojic acid * | 3.53 | 185.0992 [M + H]+ | 143, 125, 113, 97, 68 | 0.50 | [ |
| 11 | Kojic acid aldehyde * | 4.83 | 141.0650 [M + H]+ | 123, 95, 67, 43 | 5.92 | [ |
| 12 | Penicillin G | 6.11 | 356.1262 [M + Na]+ | 217, 176 | 0.46 | [ |
| 13 | Anserine * | 6.48 | 241.1167 [M + H]+ | 212, 171, 69 | 1.75 | [ |
| 14 | Penicillin G isomer | 7.87 | 356.9433 [M + Na]+ | 217, 176 | 3.34 | [ |
| 15 | N-acetyl methionine | 8.02 | 193.1551 [M + H]+ | 160, 139, 115, 104 | 4.05 | [ |
| 16 | Sorbicillin | 8.03 | 233.1105 [M + H]+ | 215, 200, 173, 145, 119 | 0.24 | [ |
| 17 | Penillic acid | 8.55 | 335.1497 [M + H]+ | 155 | 0.24 | [ |
| 18 | L-saccharopine * | 8.82 | 277.0930 [M + H]+ | 259, 231, 215, 203, 147, 84 | 4.05 | [ |
| 19 | Quinolactacide * | 9.09 | 237.1015 [M + H]+ | 209, 192, 181, 169, 154 | 0.24 | [ |
| 20 | L-saccharopine isomer | 10.29 | 277.2620 [M + H]+ | 259, 231, 215, 203, 147, 84 | 0.15 | [ |
| 21 | Camptothecin * | 10.38 | 349.1757 [M + H]+ | 305, 277, 249, 221 | 3.77 | [ |
| 22 | Camptothecin isomer | 10.98 | 349.2006 [M + H]+ | 305, 277, 249, 221 | 3.38 | [ |
| 23 | Dihydrosorbicillin | 12.37 | 235.2265 [M + H]+ | 217, 199, 188, 174, 160, 147, 133, 106, 94, 69 (100%). | 4.51 | [ |
| 24 | Sohirnone B | 12.81 | 271.1547 [M + Na]+ | 247, 229, 207, 181, 153, 94 | 0.31 | [ |
| 25 | Kynurenine * | 12.97 | 209.2372 [M + H]+ | 164, 148, 136, 118, 94 | 7.95 | [ |
| 26 | Penilloic acid * | 14.42 | 309.1964 [M + H]+ | 217, 189, 159, 148. | 0.36 | [ |
| 27 | Sohirnone B derivative | 15.17 | 475.2501 [M + H]+ | 248, 207, 180 | 0.27 | [ |
| 28 | Sorrentanone | 16.08 | 269.1486 [M + Na]+ | 250, 208, 180, 155 | 3.72 | [ |
| 29 | Sorrentanone isomer | 17.02 | 269.1831 [M + Na]+ | 250, 208, 180, 155 | 3.11 | [ |
| 30 | Fulvic acid | 18.79 | 309.1964 [M + H]+ | 231, 198, 181 | 2.82 | [ |
| 31 | Citrinin | 19.72 | 273.2188 [M + Na]+ | 255, 227, 119, 115, 91 | 0.61 | [ |
| 32 | Zearalenone | 21.98 | 319.2695 [M + H]+ | 283, 98, 83, 59 | 0.55 | [ |
| 33 | Dehydro ergosterol | 24.21 | 377.2721 [M + H-H2O]+ | 267, 252, 189, 156, 134 | 0.44 | [ |
| 34 | Stigmasterol | 27.47 | 395.3597 [M + H-H2O]+ | 311, 255, 215 | 1.09 | [ |
| 35 | Ergosta-4,6,8(14),22 tetraen-3one | 27.70 | 393.3486 [M + H]+ | 335, 268, 250, 173 | 1.11 | [ |
| 36 | Brassicasterol palmitate * | 29.91 | 639.6279 [M + H-H2O]+ | 381 | 1.62 | [ |
* Compounds first reported in Penicillium chrysogenum
Figure 1UPLS-ESI-MS chromatogram of Penicillium chrysogenum ethyl acetate extract in positive (+) ionization mode. * Unidentified compounds.
Figure 2UPLC-ESI-MS/MS chromatograms of some identified compounds ((A): amphetamine; (B): quinolactacide; (C): 3- hydroxy kojic acid; (D): fulvic acid; (E): penicillin G; (F): Kynurenine; (G): sorbicillin; (H): dihydrosorbicillin; (I): L- saccharopine; (J): sohirnone B) in Penicillium chrysogenum ethyl acetate extract in positive (+) ionization mode.
Antibacterial activity of Penicillium chrysogenum (PC) total extract and kojic acid (KA) by agar diffusion method.
| Extract/Compound | Inhibition Zone (IZ mm) Diameter (Mean ± SD)/Minimum Inhibitory Concentration (MIC µg/mL) | |||||
|---|---|---|---|---|---|---|
| Gram Positive Bacteria | Gram Negative Bacteria | |||||
| IZ | MIC | IZ | MIC | IZ | MIC | |
| Solvent (DMSO) | 10 | 10 | 19 | |||
| PC Total extract | 23 ± 0.72 | 250 ± 0.82 | - | - | - | - |
| Kojic acid (KA) | 14 ± 0.82 | >2000 ± 1.4 | 14 ± 0.59 | >2000 ± 1.5 | 25 ±0.82 | 250 ± 0.82 |
| Ciprofloxacin | - | 1.56 ± 1.2 | - | 3.125 ± 0.89 | - | 3.125 ± 0.24 |
MIC: 50–500 μg/mL (strong activity), 600–1500 μg/mL (moderate activity), >1500 μg/mL (weak activity) [18,19].
Antifungal activity of Penicillium chrysogenum (PC) total extract and kojic acid (KA) by agar diffusion method.
| Extract/ | Inhibition Zone (IZ mm) Diameter (Mean ± SD)/Minimum Inhibitory Concentration (MIC µg/mL) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Fungi | ||||||||||
| IZ | MIC | IZ | MIC | IZ | MIC | IZ | MIC | IZ | MIC | |
| PC Total | 40 ± 0.45 | 93.75 ± 0.55 | 13 ± 0.63 | 625 ± 1.3 | 10 ± 0.73 | 1000 ± 1.3 | 22 ± 0.19 | 19.53 ± 0.48 | 9 ± 0.68 | 10000 ± 1.5 |
| Kojic acid (KA) | 25 ± 0.56 | 750 ± 0.38 | 13 ± 0.48 | 312.5 ± 0.47 | 9 ± 0.72 | 5000 ± 1.4 | 18 ± 0.58 | 39.06 ± 0.98 | 19 ± 0.93 | 39.06 ± 0.85 |
| Fluconazole | 42 ± 0.58 | 50 ± 0.24 | 18 ± 1.2 | 39.06 ± 0.72 | 17 ± 0.8 | 39.06 ± 0.48 | 25 ± 0.63 | 4.88 ± 0.32 | 19 ± 0.7 | 19.53 ± 0.82 |
MIC: 50–500 μg/mL (strong activity), 600–1500 μg/mL (moderate activity), >1500 μg/mL (weak activity) [18,19].
Figure 3Antimicrobial activity of P. chrysogenum ethyl acetate extract PC(C6) and Kojic acid KA(H5) by agar dilution method with S. aureus, P. aeruginosa, and C. albicans.
Figure 4(A) The 2,2-diphyenyl-picrylhydrazyl (DPPH) radical scavenging activity of different concentrations (10–320 µg/mL) of Penicillium chrysogenum total extract (PC) and Kojic acid (KA). (B) IC50 of antioxidant activity of Penicillium chrysogenum total extract (PC), Kojic acid (KA), and ascorbic acid (positive control). DPPH in methanol (without the tested sample) was used as a negative control. Data were analyzed by using one-way ANOVA and statistical significance was calculated with Dunnett’s multiple comparisons test. * p-value < 0.05 was considered as statistically significant. The data display the mean ±SD of three biological replicas. Asterisk indicates a significant difference compared to the control (p < 0.01).
Figure 5(A) Cytotoxic activity of Penicillium chrysogenum total extract (PC) and Kojic acid (KA). DMSO and vinblastine sulphate were used as negative and positive controls, respectively, against HCT-116 cell line at different concentrations. (B) Cytotoxic activity of Penicillium chrysogenum ethyl acetate extract (PC) and kojic acid (KA) against HEP-2 cell line at different concentrations. Data were analyzed by using one-way ANOVA and statistical significance was calculated with Dunnett’s multiple comparisons test. p-value < 0.05 was considered as statistically significant. The data display the mean ±SD of three biological replicas.
Half maximum inhibitory concentration (IC50) of Penicillium chrysogenum (PC) total extract and kojic acid (KA) in cell viability of HCT-116 and HEP-2 cells after treatment for 48 h, as measured by the MTT assay. The data are presented as µg/mL.
| Cell Line | Tested Fractions | ||
|---|---|---|---|
| IC50 (µg/mL) | |||
| PC | KA | Vinblastine Sulphate | |
| HCT-116 | 22.6 ± 0.8 | 23.4 ± 1.4 | 2.34 ± 0.28 |
| HEP-2 | 30.8 ± 1.3 | 30.8 ± 1.2 | 6.61 ± 0.59 |
PC, Penicillium chrysogenum total extract; KA, kojic acid. The assay was conducted in triplicate.
Figure 6(1 and 2) The collected marine sponges (host organisms) Cliona sp. and Hymedesmia sp. (3) Isolation of endozoic fungi associated with marine sponge using malt agar and malt yeast agar media. (4) Purification of isolated strains on malt agar media. (5) Large scale fermentation on Wirkham’s media. (6) Identification of selected strain (Penicillium chrysogenum) according to the universal keys.